Skip to main content
Veterinary Medicines

Drontal Tasty Bone Wormer 150/144/50 mg tablets

Authorised
  • Febantel
  • Pyrantel embonate
  • Praziquantel

Product identification

Medicine name:
Drontal Tasty Bone Wormer 150/144/50 mg tablets
Drontal Dog Flavour, 150/144/50mg, Tableta
Active substance:
  • Febantel
  • Pyrantel embonate
  • Praziquantel
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    150.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC55
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil.Container size: Cartons containing 2 tablets
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil.Container size: Cartons containing 4 tablets
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil.Container size: Cartons containing 6 tablets
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil.Container size: Cartons containing 24 tablets
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil.Container size: Cartons containing 102 tablets
  • Container material: Blisters formed from PA/Alu/PE foil and sealed with Alu/PE foil.Container size: Cartons containing 312 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
  • EUROPHARTECH
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/077/15-C
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0338/001
Concerned member states:
  • Belgium
  • Czechia
  • Luxembourg
  • Slovakia

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
Czech (PDF)
Published on: 25/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."